Cargando…

A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer

Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. Necroptosis is a type of programmed cell death (PCD) and exhibits regulatory effects on tumor progression, but few studies have focused on the relationships between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xin, Zhang, Xingda, Li, Guozheng, Hao, Yi, Liu, Lei, Zhang, Lei, Chen, Yihai, Wu, Jiale, Wang, Xinheng, Yang, Shuai, Xu, Shouping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107037/ https://www.ncbi.nlm.nih.gov/pubmed/35578667 http://dx.doi.org/10.1155/2022/3143511

Ejemplares similares

Toward Exempting from Sentinel Lymph Node Biopsy in T1 Breast Cancer Patients: A Retrospective Study
por: Li, Guozheng, et al.
Publicado: (2022)

Riddle of the Sphinx: Emerging Role of Transfer RNAs in Human Cancer
por: Qiu, Zhilin, et al.
Publicado: (2021)

A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma
por: Zheng, Yixin, et al.
Publicado: (2022)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients
por: Zhang, Yuan, et al.
Publicado: (2022)

A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1–2 breast cancer with only one sentinel lymph node metastasis
por: Liu, Lei, et al.
Publicado: (2022)

LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1–TINCR-USP20-PD-L1 axis
por: Wang, Qin, et al.
Publicado: (2023)

A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma
por: Wu, Zhikang, et al.
Publicado: (2022)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM
por: Song, Chong, et al.
Publicado: (2022)

Derivation and Validation of a Necroptosis-Related lncRNA Signature in Patients with Ovarian Cancer
por: Zhu, Linling, et al.
Publicado: (2022)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

Identification and Validation of the lncRNA MYOSLID as a Regulating Factor of Necroptosis and Immune Cell Infiltration in Colorectal Cancer following Necroptosis-Related LncRNA Model Establishment
por: Wu, Zhiwei, et al.
Publicado: (2022)

Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
por: Luo, Jian, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer
por: Liu, Yang, et al.
Publicado: (2022)

A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
por: Yu, Zuhu, et al.
Publicado: (2022)

Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer
por: Lin, Zhiheng, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas
por: Liu, Binfeng, et al.
Publicado: (2022)

Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas
por: Lin, Zhiheng, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer
por: Du, Xinyi, et al.
Publicado: (2022)

A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
por: Meng, Zilu, et al.
Publicado: (2022)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
por: Zhao, Lei, et al.
Publicado: (2023)

Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Necroptosis‐related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer
por: Chen, Fangyue, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma
por: Luo, Lianghua, et al.
Publicado: (2022)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer
por: Zhang, Jian, et al.
Publicado: (2019)

Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA
por: Zhang, Miao, et al.
Publicado: (2023)

Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2020)

A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer
por: He, Wei-Peng, et al.
Publicado: (2022)

A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer
por: Jin, Yuzhou, et al.
Publicado: (2023)

A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors
por: Li, Han, et al.
Publicado: (2023)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma
por: Zhang, Guanghao, et al.
Publicado: (2022)

Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
por: Lyu, Hao, et al.
Publicado: (2023)

Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma
por: Lin, Hang, et al.
Publicado: (2023)

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2nt43vra9tu1fr7ijq3r4f0uri